MILD DYSLIPIDEMIA

Clinical trials for MILD DYSLIPIDEMIA explained in plain language.

Never miss a new study

Get alerted when new MILD DYSLIPIDEMIA trials appear

Sign up with your email to follow new studies for MILD DYSLIPIDEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

First human test of 'Gene Silencing' shot aims to tame bad cholesterol

Disease control Completed

This was the first study in humans of a new experimental drug called EDP167, which is designed to lower cholesterol and other blood fats (lipids). The trial tested single injections at different doses in 40 healthy volunteers and people with mildly high cholesterol to check its s…

Matched conditions: MILD DYSLIPIDEMIA

Phase: PHASE1 • Sponsor: Eddingpharm (Zhuhai) Co., Ltd. • Aim: Disease control

Last updated Mar 27, 2026 12:41 UTC

MILD DYSLIPIDEMIA

Get alerted when new MILD DYSLIPIDEMIA trials appear

First human test of 'Gene Silencing' shot aims to tame bad cholesterol